FDA Inspection
Rpk Pharmaceuticals IncRpk Pharmaceuticals Inc – FDA Inspection, Mar 8, 2012
Record Details
This FDA Inspection record concerns Rpk Pharmaceuticals Inc, with an inspection on March 8, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Rpk Pharmaceuticals Inc
- Inspection Date
- March 8, 2012
- Product Type
- Drugs
View Company Profile
ID · e780fe8e-5ff4-4a18-91b8-4e47c32f5d1a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 771926
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Rpk Pharmaceuticals Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 14, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 9, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 7, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rpk Pharmaceuticals Inc
- FDA Inspection 1155217 - 2021-10-14
- FDA Inspection 1081636 - 2019-02-28
- FDA Inspection 660576 - 2010-04-09
- FDA Inspection 603965 - 2009-08-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.